EdgarLookup

Innovaro, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Innovaro, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-1882.3%
Profit Margin
Net income ÷ revenue
-118%
Return on Assets
Net income ÷ assets
4.43x
Debt-to-Equity
Total liabilities ÷ equity
-96.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 $530.8K Apr 15, 2013
FY2011 Dec 31, 2011 $14.86M Apr 11, 2012
FY2011 Dec 31, 2010 $13.10M Apr 11, 2012

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 ($9.99M) Apr 15, 2013
FY2011 Dec 31, 2011 ($4.62M) Apr 11, 2012
FY2011 Dec 31, 2010 ($19.13M) Apr 11, 2012

R&D Expense

Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 $413.6K Apr 15, 2013
FY2011 Dec 31, 2011 $751.8K Apr 11, 2012
FY2011 Dec 31, 2010 $1.23M Apr 11, 2012

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 ($1.68M) Apr 15, 2013
FY2011 Dec 31, 2011 $650.9K Apr 11, 2012
FY2011 Dec 31, 2010 ($4.91M) Apr 11, 2012

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 $1.3K Apr 15, 2013
FY2012 Dec 31, 2011 $39.2K Apr 15, 2013

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 $8.47M Apr 15, 2013
FY2011 Dec 31, 2011 $20.77M Apr 11, 2012
FY2011 Dec 31, 2010 $24.65M Apr 11, 2012

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 $6.72M Apr 15, 2013
FY2011 Dec 31, 2011 $9.96M Apr 11, 2012
FY2011 Dec 31, 2010 $10.64M Apr 11, 2012

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 $1.52M Apr 15, 2013
FY2011 Dec 31, 2011 $10.57M Apr 11, 2012
FY2011 Dec 31, 2010 $13.49M Apr 11, 2012

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2011 Dec 31, 2011 $6.13M Apr 11, 2012
FY2011 Dec 31, 2010 $6.41M Apr 11, 2012

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 ($86.45M) Apr 15, 2013
FY2011 Dec 31, 2011 ($76.45M) Apr 11, 2012
FY2011 Dec 31, 2010 ($71.83M) Apr 11, 2012

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 $75.9K Apr 15, 2013
FY2011 Dec 31, 2011 $268.2K Apr 11, 2012
FY2011 Dec 31, 2010 $262.6K Apr 11, 2012
FY2011 Dec 31, 2009 $2.12M Apr 11, 2012

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 $5.23M Apr 15, 2013
FY2012 Dec 31, 2011 $5.64M Apr 15, 2013

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2012 Dec 31, 2012 16.15M Apr 15, 2013
FY2011 Dec 31, 2011 15.04M Apr 11, 2012
FY2011 Dec 31, 2010 14.59M Apr 11, 2012